Organovo Holdings logo
Organovo Holdings ONVO

Quarterly report 2025-Q4
added 02-11-2026

report update icon

Organovo Holdings Gross Profit 2011-2026 | ONVO

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Organovo Holdings

2025 2024 2023 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 1.87 M 2.61 M 3.57 M 3.27 M - - 379 K 220 K 1.2 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.57 M 220 K 1.87 M

Gross Profit of other stocks in the Diagnostics research industry

Issuer Gross Profit Price % 24h Market Cap Country
Centogene N.V. Centogene N.V.
CNTG
17.2 M - -6.23 % $ 30.6 M germanyGermany
Fulgent Genetics Fulgent Genetics
FLGT
107 M $ 15.48 -5.49 % $ 468 M usaUSA
Biodesix Biodesix
BDSX
18.5 M $ 13.64 -6.58 % $ 1.77 B usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
12.7 M $ 8.45 - $ 33.7 M israelIsrael
Enzo Biochem Enzo Biochem
ENZ
23.2 M - -8.98 % $ 14.8 K usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
2.26 B - - $ 19.8 B usaUSA
Akumin Akumin
AKU
53.5 M - -17.87 % $ 25.9 M canadaCanada
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
11.3 B $ 477.84 -2.25 % $ 180 B usaUSA
Heska Corporation Heska Corporation
HSKA
111 M - - $ 1.31 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
54.4 M - - $ 562 M britainBritain
IDEXX Laboratories IDEXX Laboratories
IDXX
2.66 B $ 565.93 -1.28 % $ 45.5 B usaUSA
Illumina Illumina
ILMN
2.86 B $ 118.67 -4.61 % $ 18.9 B usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
21.4 M $ 0.61 -0.62 % $ 61.9 M irlandaIrlanda
DermTech DermTech
DMTK
276 K - -11.32 % $ 2.94 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
4.32 M - -6.19 % $ 10.5 M usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
2.39 B $ 1 238.69 -2.47 % $ 25.5 B schweizSchweiz
Co-Diagnostics Co-Diagnostics
CODX
2.63 M $ 4.4 101.83 % $ 129 M usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
842 K - -61.36 % $ 2.46 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
1.06 B - - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
83.3 M - 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
-251 K - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
281 M - 0.12 % $ 80.1 M chinaChina
National Research Corporation National Research Corporation
NRC
81.5 M $ 17.21 -0.86 % $ 385 M usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
4.56 M - -20.0 % $ 1.06 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
869 M - - $ 10.7 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
958 M $ 158.35 -4.21 % $ 7.85 B usaUSA
OpGen OpGen
OPGN
366 K - -16.95 % $ 1.54 M usaUSA
Waters Corporation Waters Corporation
WAT
1.4 B $ 291.81 -2.91 % $ 17.4 B usaUSA
Biocept Biocept
BIOC
6.12 M - -13.05 % $ 7.29 M usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
6.17 K $ 4.75 3.38 % $ 2.55 M usaUSA
Personalis Personalis
PSNL
22.1 M $ 6.55 -10.52 % $ 388 M usaUSA
PerkinElmer PerkinElmer
PKI
523 M - -0.91 % $ 14.7 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
98.7 M - - $ 21.2 M usaUSA
Exagen Exagen
XGN
38.8 M $ 2.68 -4.12 % $ 57.8 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
29.9 M $ 1.73 2.37 % $ 7.59 M usaUSA
RadNet RadNet
RDNT
154 M $ 56.85 -4.31 % $ 4.27 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
-398 K - -34.28 % $ 263 K israelIsrael
QIAGEN N.V. QIAGEN N.V.
QGEN
967 M - - $ 10.6 B niderlandNiderland
Chembio Diagnostics Chembio Diagnostics
CEMI
6.58 M - 0.22 % $ 16.8 M usaUSA
Senseonics Holdings Senseonics Holdings
SENS
15.8 M $ 6.54 -0.3 % $ 273 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
4.01 B $ 266.88 -0.56 % $ 22.2 B usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
8.41 M - -1.84 % $ 15.3 M usaUSA
Precipio Precipio
PRPO
6.02 M $ 26.75 -1.65 % $ 34.7 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
81.6 M $ 17.11 -2.06 % $ 912 M usaUSA
Neuronetics Neuronetics
STIM
72.3 M $ 1.4 5.26 % $ 92.3 M usaUSA
Quotient Limited Quotient Limited
QTNT
23.3 M - -11.32 % $ 1.1 M schweizSchweiz